Indianapolis-based Eli Lilly & Co. has named Levi Garraway senior vice president of global development and medical affairs for Lilly Oncology. He will begin his new role January 1, following the retirement of Richard Gaynor. Garraway currently serves as professor of medicine at Harvard Medical School in Massachusetts. He is also the director of the Joint Center for Cancer Precision Medicine, which spans the Harvard teaching hospitals. Garraway is also the co-leader of the Cancer Genetics Program at the Dana-Farber/Harvard Cancer Center.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}